Literature DB >> 32234851

When thyroid labs do not add up, physicians should ask patients about biotin supplements.

Michael S Lundin1,2, Ahmad Alratroot3,2, Fawzi Abu Rous3,2, Saleh Aldasouqi2,4.   

Abstract

A 69-year-old woman with a remote history of Graves' disease treated with radioactive iodine ablation, who was maintained on a stable dose of levothyroxine for 15 years, presented with abnormal and fluctuating thyroid function tests which were confusing. After extensive evaluation, no diagnosis could be made, and it became difficult to optimise the levothyroxine dose, until we became aware of the recently recognised biotin-induced lab interference. It was then noticed that her medication list included biotin 10 mg two times per day. After holding the biotin and repeating the thyroid function tests, the labs made more sense, and the patient was easily made euthyroid with appropriate dose adjustment. We also investigated our own laboratory, and identified the thyroid labs that are performed with biotin-containing assays and developed strategies to increase the awareness about this lab artefact in our clinics. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endocrine system; general practice / family medicine; skin; thyroid disease; vitamins and supplements

Mesh:

Substances:

Year:  2020        PMID: 32234851      PMCID: PMC7167425          DOI: 10.1136/bcr-2019-231337

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Fake news? Biotin interference in thyroid immunoassays.

Authors:  Viktoria F Koehler; Ulrike Mann; Ayham Nassour; W A Mann
Journal:  Clin Chim Acta       Date:  2018-05-30       Impact factor: 3.786

2.  Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone.

Authors:  Théo Willeman; Olivier Casez; Patrice Faure; Anne Sophie Gauchez
Journal:  Clin Chem Lab Med       Date:  2017-08-28       Impact factor: 3.694

3.  Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study.

Authors:  Nilika G Wijeratne; James C G Doery; Zhong X Lu
Journal:  Pathology       Date:  2012-12       Impact factor: 5.306

4.  Biotin Treatment Mimicking Graves' Disease.

Authors:  Sebastian Kummer; Derik Hermsen; Felix Distelmaier
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

5.  High doses of biotin in chronic progressive multiple sclerosis: a pilot study.

Authors:  Frédéric Sedel; Caroline Papeix; Agnès Bellanger; Valérie Touitou; Christine Lebrun-Frenay; Damien Galanaud; Olivier Gout; Olivier Lyon-Caen; Ayman Tourbah
Journal:  Mult Scler Relat Disord       Date:  2015-01-24       Impact factor: 4.339

6.  Biochemical Hyperthyroidism in a Newborn Baby Caused by Assay Interaction from Biotin Intake.

Authors:  Inge Bülow Pedersen; Peter Laurberg
Journal:  Eur Thyroid J       Date:  2016-08-12

Review 7.  Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm.

Authors:  Julien Favresse; Maria-Cristina Burlacu; Dominique Maiter; Damien Gruson
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 8.  Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.

Authors:  Marianne S Elston; Shekhar Sehgal; Stephen Du Toit; Tania Yarndley; John V Conaglen
Journal:  J Clin Endocrinol Metab       Date:  2016-06-30       Impact factor: 5.958

9.  Comprehensive assessment of biotin interference in immunoassays.

Authors:  Jieli Li; Elizabeth A Wagar; Qing H Meng
Journal:  Clin Chim Acta       Date:  2018-10-05       Impact factor: 3.786

10.  Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses.

Authors:  Giuseppe Barbesino
Journal:  Thyroid       Date:  2016-04-28       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.